149 related articles for article (PubMed ID: 15633456)
21. Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase.
Hanada K; Hara T; Fukasawa M; Yamaji A; Umeda M; Nishijima M
J Biol Chem; 1998 Dec; 273(50):33787-94. PubMed ID: 9837968
[TBL] [Abstract][Full Text] [Related]
22. Function of Platelet Glycosphingolipid Microdomains/Lipid Rafts.
Komatsuya K; Kaneko K; Kasahara K
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32748854
[TBL] [Abstract][Full Text] [Related]
23. Lysenin-His, a sphingomyelin-recognizing toxin, requires tryptophan 20 for cation-selective channel assembly but not for membrane binding.
Kwiatkowska K; Hordejuk R; Szymczyk P; Kulma M; Abdel-Shakor AB; Płucienniczak A; Dołowy K; Szewczyk A; Sobota A
Mol Membr Biol; 2007; 24(2):121-34. PubMed ID: 17453419
[TBL] [Abstract][Full Text] [Related]
24. Detergent-resistant membranes and the protein composition of lipid rafts.
Magee AI; Parmryd I
Genome Biol; 2003; 4(11):234. PubMed ID: 14611651
[TBL] [Abstract][Full Text] [Related]
25. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
Waheed AA; Shimada Y; Heijnen HF; Nakamura M; Inomata M; Hayashi M; Iwashita S; Slot JW; Ohno-Iwashita Y
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4926-31. PubMed ID: 11309501
[TBL] [Abstract][Full Text] [Related]
26. Non-senescent keratinocytes organize in plasma membrane submicrometric lipid domains enriched in sphingomyelin and involved in re-epithelialization.
Mound A; Lozanova V; Warnon C; Hermant M; Robic J; Guere C; Vie K; Lambert de Rouvroit C; Tyteca D; Debacq-Chainiaux F; Poumay Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):958-971. PubMed ID: 28599891
[TBL] [Abstract][Full Text] [Related]
27. Biology of lysenin, a protein in the coelomic fluid of the earthworm Eisenia foetida.
Kobayashi H; Ohta N; Umeda M
Int Rev Cytol; 2004; 236():45-99. PubMed ID: 15261736
[TBL] [Abstract][Full Text] [Related]
28. Lysenin, a novel sphingomyelin-specific binding protein.
Yamaji A; Sekizawa Y; Emoto K; Sakuraba H; Inoue K; Kobayashi H; Umeda M
J Biol Chem; 1998 Feb; 273(9):5300-6. PubMed ID: 9478988
[TBL] [Abstract][Full Text] [Related]
29. Oligomerization and pore formation of a sphingomyelin-specific toxin, lysenin.
Yamaji-Hasegawa A; Makino A; Baba T; Senoh Y; Kimura-Suda H; Sato SB; Terada N; Ohno S; Kiyokawa E; Umeda M; Kobayashi T
J Biol Chem; 2003 Jun; 278(25):22762-70. PubMed ID: 12676961
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol and lipid/protein ratio control the oligomerization of a sphingomyelin-specific toxin, lysenin.
Ishitsuka R; Kobayashi T
Biochemistry; 2007 Feb; 46(6):1495-502. PubMed ID: 17243772
[TBL] [Abstract][Full Text] [Related]
31. Rafts--the current picture.
Grzybek M; Kozubek A; Dubielecka P; Sikorski AF
Folia Histochem Cytobiol; 2005; 43(1):3-10. PubMed ID: 15871556
[TBL] [Abstract][Full Text] [Related]
32. Exposure of phosphatidylinositol transfer proteins to sphingomyelin-cholesterol membranes suggests transient but productive interactions with raft-like, liquid-ordered domains.
Miller EC; Helmkamp GM
Biochemistry; 2003 Nov; 42(45):13250-9. PubMed ID: 14609336
[TBL] [Abstract][Full Text] [Related]
33. Recognition of sphingomyelin by lysenin and lysenin-related proteins.
Kiyokawa E; Makino A; Ishii K; Otsuka N; Yamaji-Hasegawa A; Kobayashi T
Biochemistry; 2004 Aug; 43(30):9766-73. PubMed ID: 15274631
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of action of sphingomyelin-specific pore-forming toxin, lysenin.
Yilmaz N; Yamaji-Hasegawa A; Hullin-Matsuda F; Kobayashi T
Semin Cell Dev Biol; 2018 Jan; 73():188-198. PubMed ID: 28751253
[TBL] [Abstract][Full Text] [Related]
35. Domain-specific lipid distribution in macrophage plasma membranes.
Gaus K; Rodriguez M; Ruberu KR; Gelissen I; Sloane TM; Kritharides L; Jessup W
J Lipid Res; 2005 Jul; 46(7):1526-38. PubMed ID: 15863834
[TBL] [Abstract][Full Text] [Related]
36. Secondary structure and orientation of the pore-forming toxin lysenin in a sphingomyelin-containing membrane.
Hereć M; Gagoś M; Kulma M; Kwiatkowska K; Sobota A; Gruszecki WI
Biochim Biophys Acta; 2008 Apr; 1778(4):872-9. PubMed ID: 18178147
[TBL] [Abstract][Full Text] [Related]
37. Is a fluid-mosaic model of biological membranes fully relevant? Studies on lipid organization in model and biological membranes.
Wiśniewska A; Draus J; Subczynski WK
Cell Mol Biol Lett; 2003; 8(1):147-59. PubMed ID: 12655369
[TBL] [Abstract][Full Text] [Related]
38. Lipid microdomains in model and biological membranes: how strong are the connections?
Silvius J
Q Rev Biophys; 2005 Nov; 38(4):373-83. PubMed ID: 16600056
[TBL] [Abstract][Full Text] [Related]
39. Sphingomyelin and its role in cellular signaling.
Chakraborty M; Jiang XC
Adv Exp Med Biol; 2013; 991():1-14. PubMed ID: 23775687
[TBL] [Abstract][Full Text] [Related]
40. Nanodomains in biological membranes.
Ma Y; Hinde E; Gaus K
Essays Biochem; 2015; 57():93-107. PubMed ID: 25658347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
